• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Good news! Pfizer CEO said life will return to normal by end of 2022

ginfreely

Alfrescian
Loyal
Joined
Nov 9, 2010
Messages
80,049
Points
113

Pfizer CEO sees a return to ‘normal’ globally by the end of 2022​

PUBLISHED WED, JUN 16 202111:47 AM EDTUPDATED 5 MIN AGO

Berkeley Lovelace Jr.@BERKELEYJR
SHAREShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email
KEY POINTS
  • Pfizer CEO Albert Bourla told CNBC he expects life could return to normal for developed countries by the end of this year and the rest of the world by the end of 2022.
  • By the end of next year, there should be enough Covid-19 vaccine doses for most world leaders to successfully inoculate their populations against the virus, he said.
https://www.cnbc.com/2021/06/16/cov...rn-to-normal-globally-at-the-end-of-2022.html
 
Pfizer CEO Albert Bourla told CNBC on Wednesday he expects life could return to normal for developed countries by the end of this year and the rest of the world by the end of 2022.

By the end of next year, there should be enough Covid-19 vaccine doses for most world leaders to successfully inoculate their populations against the virus, Bourla said during an interview with Andrew Ross Sorkin at the CNBC Evolve Global Summit.
 
“I think the whole world will have enough volumes [of vaccine doses] by the end of 2022 to vaccinate, to protect everyone,” he said. “And I think that by the end of this year, the developed world will already be in this situation.”

Pfizer and German partner BioNTech reached the milestone of manufacturing 1 billion doses of their Covid vaccine last week, Bourla told CNBC. The two companies expect to produce up to 3 billion doses this year.

The vaccine, one of three authorized for use in the U.S., has played a major role in driving down the number of new infections and hospitalizations across the country. As many states begin to lift their Covidrestrictions and return to normal, leaders from other countries are urging the U.S. to donate leftover shots.
 
Pfizer and BioNTech previously pledged to provide 2 billion doses of the vaccine to low- and middle-income countries.

The drugmakers plan to provide the U.S. government with 500 million doses of the vaccine, enough to inoculate 250 million people since it requires two doses given three weeks apart. As part of the plan, the United States said it will allocate the vaccine doses to 92 low- and lower-middle-income countries.
 
The U.S. has committed to donating 80 million Covid shots from four drugmakers. It plans to allocate the majority of the vaccines through COVAX, the World Health Organization-backed global vaccine sharing program.

Bourla said Pfizer has contracts with more than 120 countries around the world. The majority of the vaccine doses so far have gone to developed countries, he said, because they placed their orders for the shots in advance.

He said he expects more vaccines to go toward poorer countries in the second half of this year as developed nations finish vaccinating their populations.

The company is also preparing to manufacture booster shots, he said. The CEO has previously told CNBC that people will likely need booster doses within 12 months of getting fully vaccinated and potentially additional doses annually.

He also touted that the company is working on treatments for those who do get infected.

Bourla told CNBC in April that the company’s experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year.

Correction: Pfizer and BioNTech expect to produce up to 3 billion doses of their vaccine this year. An earlier version misstated the figure.
 

Good news! Pfizer CEO said life will return to normal by end of 2022 WITH ENOUGH VACCINE FOR THE WHOLE WORLD TO PROTECT EVERYONE​

 
“I think the whole world will have enough volumes [of vaccine doses] by the end of 2022 to vaccinate, to protect everyone,” he said. “And I think that by the end of this year, the developed world will already be in this situation.”
Angmoh the best
 
1 (updated) booster shot every 6.9 months for 6.9 billion. at $69 per shot, that will be about $952b every year. huat ah!
 
That will be too late for many.its already starting to normalise in places where vaccination rates are high.
Latest by october this year, all countries should open up.
 
1 (updated) booster shot every 6.9 months for 6.9 billion. at $69 per shot, that will be about $952b every year. huat ah!
Looks like I better take non mrna vaccine as booster shots in the long run as I am also high risk in heart disease as my father had heart disease too.
 
That will be too late for many.its already starting to normalise in places where vaccination rates are high.
Latest by october this year, all countries should open up.
Ya look at USA europe all no mask on the street already. Stupid Singapore is obviously not in developed world.
 
yet another ginfugly "rub own pussy until song" and "dua pao sien" kind of thread. :rolleyes:
 
yet another ginfugly "rub own pussy until song" and "dua pao sien" kind of thread. :rolleyes:
What rubbish I am spreading good news to people that think there is no end to the pandemic. Pfizer ceo is definitely an expert on the virus.
 
yet another ginfugly "rub own pussy until song" and "dua pao sien" kind of thread. :rolleyes:
Pui you evil filthy liar son of whore. Only you are tao pao sien while my threads state facts and no where tao pao sien.
 
Another talk cock sing song fellow...

LAter 2025 still like this...
He is obviously a doer and not tcss kind to push Pfizer staff to be first one to deliver the vaccine in record speed.
 
https://www.linkedin.com/in/albert-bourla

About​

I became Chief Executive Officer at Pfizer, one of the world's premier innovative biopharmaceutical companies, on January 1, 2019.

In my previous role as Chief Operating Officer (COO), I oversaw the company's commercial, strategy, manufacturing and global product development functions.

Prior to being named COO, I was the Group President of Pfizer Innovative Health, responsible for the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. I also created the Patient and Health Impact group, which is dedicated to developing solutions for increasing patient access, demonstrating the value of our innovations, and ensuring broader business model innovation.

I have 25 years of experience with Pfizer and have held a number of senior global positions across a range of markets and disciplines. Previously, I was the Group President of Pfizer's Global Vaccines, Oncology and Consumer Healthcare business. Before that, I was President and General Manager of Pfizer's Established Products business, leading the development and implementation of strategies and tactics related to Pfizer's off-patent portfolio (including legacy brands and generics).

I've also held a number of positions of increasing responsibility in Animal Health and Marketing. Prior to joining Pfizer, I was a practicing Veterinarian in Greece.

I am a board member for the Pfizer Foundation, which promotes access to quality health care and the Biotechnology Innovation Organization (Bio), the world's largest biotechnology trade association, where I serve on the Executive Committee.
 
https://greekreporter.com/2020/11/10/a-greek-to-save-the-world-who-is-pfizer-ceo-albert-bourla/

Dr. Bourla is a Thessaloniki native who left Greece at the age of 34 to pursue a career in the pharmaceuticals industry.

Born in the northern Greececity on October 21, 1961, he is part of the long history of the Sephardic Jews of Thessaloniki.

Pfizer CEO Albert Bourla born and raised in Thessaloniki​

The Bourla family arrived in Thessaloniki from Spain about six centuries ago. As jewelers, they created and sold diamonds, jewelry and watches throughout the Balkans, and built two important buildings in the city, one of which is the Moroccan Mansion.

Albert Bourla is a descendant of the few survivors of the Jewish community of the city which was almost completely wiped out by the Nazis during World War II.

After graduating from high school, the Pfizer CEO went on to study at the Aristotle University of Thessaloniki. He graduated with a PhD in veterinary medicine and worked as a veterinarian for a time.
 
He joined Pfizer in 1993, first serving as a doctor of veterinary medicine and technical director for the company’s animal health division in Greece.

At the age of 34 he left Thessaloniki with his wife to join Pfizer Europe and work in several positions, coming to live in four different countries.

He served as Pfizer’s Animal Health division president for Europe, Africa and Middle East during 2005–2009, followed by the Europe, Africa, and Asia Pacific division during 2009–2010.

He also worked as Group President of Pfizer’s Global Vaccines, Oncology and Consumer Healthcare business.

Albert Bourla became Pfizer’s CEO in 2019​

After working for Pfizer for 25 years, he was promoted to Chief Operating Officer (COO) on January 1st 2018, and on January 1st 2019 he became Pfizer’s Chief Executive Officer.
 
Back
Top